Crossmark

Vincristine exerts antiglioma effects by inhibiting the PI3K/AKT signaling pathway: A mechanistic study based on network pharmacology, bioinformatics analysis, and experimental validation

Crossref DOI link: https://doi.org/10.1007/s00210-024-03693-5

Published Online: 2024-12-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Zhihua

Wang, Jiahong

He, Ting

Rao, Donggen

Wang, Ziyang

Zhu, Jianming
Funding

Funding for this research was provided by:

Jiangxi Province health science and technology project (SKJB220203680)
License Information

Text and Data Mining valid from 2024-12-24

Version of Record valid from 2024-12-24
More Information

Article History

Received: 30 May 2024

Accepted: 27 November 2024

First Online: 24 December 2024

Declarations

:

: The authors declare no competing interests.

: This study does not involve ethical issues.

Document is current

Any future updates will be listed below